Ruderman, Eric M.
Article History
First Online: 28 April 2015
Competing interests
: The author declares that he has acted as a consultant for AbbVie, Amgen, Celgene, Janssen, Lilly, Medac, Novartis, Pharmacyclics and Vertex, and has received grant or research support from AbGenomics, Amgen, Celgene and Pharmacyclics.